Marilyn L Moy1, Riley J Collins2, Carlos H Martinez3, Reema Kadri4, Pia Roman4, Robert G Holleman4, Hyungjin Myra Kim5, Huong Q Nguyen6, Miriam D Cohen7, David E Goodrich4, Nicholas D Giardino8, Caroline R Richardson9. 1. Department of Veterans Affairs, Rehabilitation Research and Development Service, and the Pulmonary and Critical Care Medicine Section, VA Boston Healthcare System, Harvard Medical School, Boston, MA. 2. University of Michigan Medical School, Ann Arbor, MI. 3. Pulmonary and Critical Care Division, University of Michigan Health System, Ann Arbor, MI. 4. VA Center for Clinical Management Research, Health Services Research and Development Center of Innovation, VA Ann Arbor Healthcare System, Ann Arbor, MI. 5. VA Center for Clinical Management Research, Health Services Research and Development Center of Innovation, VA Ann Arbor Healthcare System, Ann Arbor, MI; University of Michigan School of Public Health, Ann Arbor, MI. 6. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA. 7. VA New York Harbor, Brooklyn, NY. 8. Department of Psychiatry, University of Michigan, Ann Arbor, MI. 9. VA Center for Clinical Management Research, Health Services Research and Development Center of Innovation, VA Ann Arbor Healthcare System, Ann Arbor, MI; Department of Family Medicine, University of Michigan, Ann Arbor, MI. Electronic address: caroli@umich.edu.
Abstract
BACKGROUND:Low levels of physical activity (PA) are associated with poor outcomes in people with COPD. Interventions to increase PA could improve outcomes. METHODS: We tested the efficacy of a novel Internet-mediated, pedometer-based exercise intervention. Veterans with COPD (N = 239) were randomized in a 2:1 ratio to the (1) intervention group (Omron HJ-720 ITC pedometer and Internet-mediated program) or (2) wait-list control group (pedometer). The primary outcome was health-related quality of life (HRQL), assessed by the St. George's Respiratory Questionnaire (SGRQ), at 4 months. We examined the SGRQ total score (SGRQ-TS) and three domain scores: Symptoms, Activities, and Impact. The secondary outcome was daily step counts. Linear regression models assessed the effect of intervention on outcomes. RESULTS:Participants had a mean age of 67 ± 9 years, and 94% were men. There was no significant between-group difference in mean 4-month SGRQ-TS (2.3 units, P = .14). Nevertheless, a significantly greater proportion of intervention participants than control subjects had at least a 4-unit improvement in SGRQ-TS, the minimum clinically important difference (53% vs 39%, respectively, P = .05). For domain scores, the intervention group had a lower (reflecting better HRQL) mean than the control group by 4.6 units for Symptoms (P = .046) and by 3.3 units for Impact (P = .049). There was no significant difference in Activities score between the two groups. Compared with the control subjects, intervention participants walked 779 more steps per day at 4 months (P = .005). CONCLUSIONS: An Internet-mediated, pedometer-based walking program can improve domains of HRQL and daily step counts at 4 months in people with COPD. TRIAL REGISTRY: Clinical Trials.gov; No.: NCT01102777; URL: www.clinicaltrials.gov.
RCT Entities:
BACKGROUND: Low levels of physical activity (PA) are associated with poor outcomes in people with COPD. Interventions to increase PA could improve outcomes. METHODS: We tested the efficacy of a novel Internet-mediated, pedometer-based exercise intervention. Veterans with COPD (N = 239) were randomized in a 2:1 ratio to the (1) intervention group (Omron HJ-720 ITC pedometer and Internet-mediated program) or (2) wait-list control group (pedometer). The primary outcome was health-related quality of life (HRQL), assessed by the St. George's Respiratory Questionnaire (SGRQ), at 4 months. We examined the SGRQ total score (SGRQ-TS) and three domain scores: Symptoms, Activities, and Impact. The secondary outcome was daily step counts. Linear regression models assessed the effect of intervention on outcomes. RESULTS:Participants had a mean age of 67 ± 9 years, and 94% were men. There was no significant between-group difference in mean 4-month SGRQ-TS (2.3 units, P = .14). Nevertheless, a significantly greater proportion of intervention participants than control subjects had at least a 4-unit improvement in SGRQ-TS, the minimum clinically important difference (53% vs 39%, respectively, P = .05). For domain scores, the intervention group had a lower (reflecting better HRQL) mean than the control group by 4.6 units for Symptoms (P = .046) and by 3.3 units for Impact (P = .049). There was no significant difference in Activities score between the two groups. Compared with the control subjects, intervention participants walked 779 more steps per day at 4 months (P = .005). CONCLUSIONS: An Internet-mediated, pedometer-based walking program can improve domains of HRQL and daily step counts at 4 months in people with COPD. TRIAL REGISTRY: Clinical Trials.gov; No.: NCT01102777; URL: www.clinicaltrials.gov.
Authors: William B Weeks; Lewis E Kazis; Yujing Shen; Zhongxiao Cong; Xinhua S Ren; Donald Miller; Austin Lee; Jonathan B Perlin Journal: Am J Public Health Date: 2004-10 Impact factor: 9.308
Authors: Fabio Pitta; Thierry Troosters; Martijn A Spruit; Vanessa S Probst; Marc Decramer; Rik Gosselink Journal: Am J Respir Crit Care Med Date: 2005-01-21 Impact factor: 21.405
Authors: Maarten J Fischer; Margreet Scharloo; Jannie J Abbink; Alex J van 't Hul; Dirk van Ranst; Arjan Rudolphus; John Weinman; Klaus F Rabe; Adrian A Kaptein Journal: Respir Med Date: 2009-05-29 Impact factor: 3.415
Authors: Martijn A Spruit; Sally J Singh; Chris Garvey; Richard ZuWallack; Linda Nici; Carolyn Rochester; Kylie Hill; Anne E Holland; Suzanne C Lareau; William D-C Man; Fabio Pitta; Louise Sewell; Jonathan Raskin; Jean Bourbeau; Rebecca Crouch; Frits M E Franssen; Richard Casaburi; Jan H Vercoulen; Ioannis Vogiatzis; Rik Gosselink; Enrico M Clini; Tanja W Effing; François Maltais; Job van der Palen; Thierry Troosters; Daisy J A Janssen; Eileen Collins; Judith Garcia-Aymerich; Dina Brooks; Bonnie F Fahy; Milo A Puhan; Martine Hoogendoorn; Rachel Garrod; Annemie M W J Schols; Brian Carlin; Roberto Benzo; Paula Meek; Mike Morgan; Maureen P M H Rutten-van Mölken; Andrew L Ries; Barry Make; Roger S Goldstein; Claire A Dowson; Jan L Brozek; Claudio F Donner; Emiel F M Wouters Journal: Am J Respir Crit Care Med Date: 2013-10-15 Impact factor: 21.405
Authors: Jeffrey P Haibach; Michael Ann Haibach; Katherine S Hall; Robin M Masheb; Melissa A Little; Robyn L Shepardson; Anne C Dobmeyer; Jennifer S Funderburk; Christopher L Hunter; Margaret Dundon; Leslie R M Hausmann; Stephen K Trynosky; David E Goodrich; Amy M Kilbourne; Sara J Knight; Gerald W Talcott; Michael G Goldstein Journal: J Behav Med Date: 2016-09-27
Authors: Emily S Wan; Ana Kantorowski; Diana Homsy; Merilee Teylan; Reema Kadri; Caroline R Richardson; David R Gagnon; Eric Garshick; Marilyn L Moy Journal: Respir Med Date: 2017-07-25 Impact factor: 3.415
Authors: Bruce G Bender; Ann Depew; Amanda Emmett; Kelly Goelz; Barry Make; Sanjay Sharma; Jennifer Underwood; David Stempel Journal: Chronic Obstr Pulm Dis Date: 2016-10-07
Authors: Emily S Wan; Ana Kantorowski; Madeline Polak; Reema Kadri; Caroline R Richardson; David R Gagnon; Eric Garshick; Marilyn L Moy Journal: Respir Med Date: 2020-01-11 Impact factor: 3.415
Authors: Marilyn L Moy; Peter M Wayne; Daniel Litrownik; Douglas Beach; Elizabeth S Klings; Roger B Davis; Gloria Y Yeh Journal: Contemp Clin Trials Date: 2015-09-08 Impact factor: 2.226
Authors: Valentin Prieto-Centurion; Nina Bracken; Lourdes Norwick; Farhan Zaidi; Amelia A Mutso; Victoria Morken; David B Coultas; Cynthia S Rand; David X Marquez; Jerry A Krishnan Journal: Chronic Obstr Pulm Dis Date: 2016